India's Pharmaceutical Exports

Country Profile

Gambia

Gambia is an emerging destination for Indian pharmaceutical exports — $9.34M in FY 2025–26, with 3.6× growth over the past decade. Medicines accounts for 86% of shipments, with vaccines contributing $901K. The compound annual growth rate since FY2015 stands at 12.3%.

🇬🇲 $9.34M · 3.6× growth since FY2015 · 12.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$9.34M
Exports FY2025–26 DGCIS
3.6×
Growth FY2015→2026
12.3%
CAGR FY2015→2026
86%
Medicines Share
5
Product Categories Supplied
Gambia is an emerging destination for Indian pharmaceutical exports — $9.34M in FY 2025–26, with 3.6× growth over the past decade. Medicines accounts for 86% of shipments, with vaccines contributing $901K. The compound annual growth rate since FY2015 stands at 12.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $8.05M (86.2%) Vaccines $901K (9.6%) Surgical & Hospital Supplies $327K (3.5%) Traditional & Herbal $55K (0.6%) Medicine Ingredients $6K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Gambia in the RBI overseas direct investment dataset (2011–2026).